Local TLR4 stimulation augments in situ vaccination induced via local radiation and anti-CTLA-4 checkpoint blockade through induction of CD8 T-cell independent Th1 polarization is a research paper published in Journal for ImmunoTherapy of Cancer (2022). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1DP5OD024576
National Institutes of Health
Grant: F30CA250263
National Institutes of Health
Grant: P01CA250972
National Institutes of Health
Grant: P30 CA014520
National Institutes of Health
Grant: P50 DE026787
National Institutes of Health
Grant: R35CA197078
National Institutes of Health
Grant: T32GM140935
National Institutes of Health
Grant: TL1TR002375
National Institutes of Health
Grant: U01CA233102
NIH HHS
Grant: DP5 OD024576
National Institutes of Health
Grant: 5TL1TR002375-04
NRSA Training Core
National Institutes of Health
Grant: 5P30CA014520-18
CANCER CENTER SUPPORT
National Institutes of Health
Grant: 5F30CA250263-02
Brachytherapy to achieve in situ cancer vaccination
National Institutes of Health
Grant: 1R35CA197078-01
Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome
National Institutes of Health
Grant: 5P01CA250972-02
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
National Institutes of Health
Grant: 5DP5OD024576-02
Combining Radiation and Tumor-specific AntIbody Therapies to Elicit in Situ Tumor Vaccination
National Institutes of Health
Grant: 5T32GM140935-02
Integrated Training For Physician-Scientists
National Institutes of Health
Grant: 5U01CA233102-04
Immunomodulation of the Tumor Microenvironment with Molecular Targeted Radiotherapy to Facilitate an Adaptive Anti-Tumor Immune Response to Combined Modality Immunotherapies
National Institutes of Health
Grant: 5P50DE026787-02
Head and Neck Cancer SPORE at the University of Wisconsin
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals